Characteristics and treatment results of refractory and relapsed acute myeloid leukaemia in paediatric patients treated in Polish Paediatric Leukaemia/Lymphoma Study Group institutions according to the Protocol Acute Myeloid Leukaemia BerlinFrankfurt-Munster 2012 and a review of novel treatment possibilities in paediatric acute myeloid leukaemia

被引：0

作者：

Samborska, Magdalena ^{[1
,18
]}

Skalska-Sadowska, Jolanta ^{[1
]}

Achkar, Robert ^{[2
]}

Wachowiak, Jacek ^{[1
]}

Derwich, Katarzyna ^{[1
]}

Czogala, Malgorzata ^{[3
]}

Balwierz, Walentyna ^{[3
]}

Skoczen, Szymon ^{[3
]}

Dobaczewski, Grzegorz ^{[4
]}

Chybicka, Alicja ^{[4
]}

Kalwak, Krzysztof ^{[4
]}

Krawczuk-Rybak, Maryna ^{[5
]}

Muszynska-Rostan, Katarzyna ^{[5
]}

Adamkiewicz-Droiynska, Elzbieta ^{[6
]}

Maciejka-Kapuscinska, Lucyna ^{[6
]}

Irga-Jaworska, Ninela ^{[6
]}

Pohorecka, Joanna ^{[7
]}

Chodata-Grzywacz, Agnieszka ^{[7
]}

Karolczyk, Graiyna ^{[7
]}

Wojcik, Beata ^{[7
]}

Kowalczyk, Jerzy R. ^{[8
]}

Drabko, Katarzyna ^{[8
]}

Zawitkowska, Joanna ^{[8
]}

Mycko, Katarzyna ^{[9
]}

Badowska, Wanda ^{[9
]}

Ociepa, Tomasz ^{[10
]}

Urasinski, Tomasz ^{[10
]}

Sikorska-Fic, Barbara ^{[11
]}

Matysiak, Michal ^{[11
]}

Laguna, Pawel ^{[11
]}

Dabrowska-Pawliszyn, Anna ^{[12
]}

Tomaszewska, Renata ^{[12
]}

Szczepanski, Tomasz ^{[12
]}

Sobol, Graiyna ^{[13
]}

Mizia-Malarz, Agnieszka ^{[13
]}

Ciebiera, Malgorzata ^{[14
]}

Chaber, Radoslaw ^{[14
]}

Koltan, Sylwia ^{[15
]}

Wysocki, Mariusz ^{[15
]}

Styczynski, Jan ^{[15
]}

Woszczyk, Mariola ^{[16
]}

Wieczorek, Maria ^{[16
]}

Karpinska-Derda, Irena ^{[16
]}

Urbanska-Rakus, Justyna ^{[16
]}

Bobeff, Katarzyna ^{[17
]}

Trelinska, Joanna ^{[17
]}

Mlynarski, Wojciech ^{[17
]}

机构：

[1] Univ Med Sci, Dept Pediat Hematol Oncol & TransplantolOncol & T, Poznan, Poland

[2] Univ Med Sci, Poznan, Poland

[3] Univ Children Hosp, Dept Pediat Oncol & Hematol, Krakow, Poland

[4] Wroclaw Med Univ, Clin Dept Pediat Bone Marrow Transplantat Oncol &, Wroclaw, Poland

[5] Med Univ, Dept Pediat Oncol & Hematol, Bialystok, Poland

[6] Med Univ, Dept Pediat Hematol & Oncol, Gdansk, Poland

[7] Reg Polyclin Hosp, Dept Pediat Hematol & Oncol, Kielce, Poland

[8] Med Univ, Dept Pediat Hematol Oncol & Transplantol, Lublin, Poland

[9] Prov Childrens Hosp, Dept Pediat & Hematol & Oncol, Olsztyn, Poland

[10] Pomeranian Med Univ, Dept Pediat HematoOncol & Gastroenterol, Szczecin, Poland

[11] Med Univ, Dept Oncol Pediat Hematol Transplantol & Pediat, Warsaw, Poland

[12] Silesian Univ Med, Dept Pediat Hematol & Oncol, Zabrze, Poland

[13] Med Univ Silesia, Katowice, Poland

[14] Clin Prov Hosp, Dept Pediat Oncohematol, Rzeszow, Poland

[15] Nicolaus Copernicus Univ Torun, Dept Pediat Hematol & Oncol, Coll Medicum, Bydgoszcz, Poland

[16] Pediat Ctr, Dept Pediat Hematol & Oncol, Chorzow, Poland

[17] Med Univ, Dept Pediat Oncol & Hematol, Lodz, Poland

[18] Uniwersytet Med Karola Marcinkowskiego, Klin Onkol Hematol & Transplantol Pediat, Poznan, Poland

来源：

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY | 2023年 / 27卷 / 04期

关键词：

children; acute myeloid leukaemia; relapse; refractory; novel therapies; CHILDREN; RECOMMENDATIONS; CHEMOTHERAPY; CYTARABINE; MANAGEMENT; DIAGNOSIS;

D O I：

10.5114/wo.2023.135327

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Introduction: This study aimed to present the clinical features and results of treatment of patients diagnosed with refractory or relapsed acute myeloid leukaemia (AML) in Polish Paediatric Leukaemia/Lymphoma Study Group (PPL/LSG) institutions, treated in accordance with the Protocol Acute Myeloid Leukaemia Berlin -Frankfurt -Munster 2012, as their first -line therapy. Material and methods: The outcome data of 10 patients with refractory AML (median age 9.5 years) and 30 with relapsed AML (median age 12 years) were analysed retrospectively. Re -induction was usually based on idarubicin, fludarabine, and cytarabine along with allogeneic haematopoietic stem cell transplant (allo-HSCT) in 5 patients with refractory AML and 7 relapsed AML children. Results: 37.5% (3/8) of refractory AML patients achieved second complete remission second complete remission (CRII). One of ten patients (1/10; 10%) was alive and stayed in complete remission for 34 months after the allo-HSCT. The probability of 3 -year event -free survival (pEFS) in this group was 0.125 +/- 0.11. In the group of relapsed AML patients, the CRII was achieved in 9 patients (34%), and the probability of survival was: pEFS = 0.24 +/- 0.08; probability overall survival (pOS) = 0.34 +/- 0.09, with significantly better results achieved in patients who underwent allo-HSCT (pOS = 0.54 +/- 0.14 vs. 0.08 +/- 0.08, p < 0.0001). Conclusions: The prognosis of refractory AML and the first AML recurrence in children who were first -line treated in PPL/LSG centres according to Protocol Acute Myeloid Leukaemia Berlin -Frankfurt -Munster 2012 is poor. Failures of re -induction treatment particularly result from difficulties in achieving remission. Allogeneic HSCT improves prognosis in children with refractory and first recurrent AML, under the condition it is performed in complete remission. Novel therapeutic approaches are needed to increase the remission rate and improve the outcomes.

引用

页码：249 / 254

页数：6

共 50 条

[1] How I treat paediatric relapsed acute myeloid leukaemia
Kaspers, Gertjan
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (05) : 636 - 645
[2] Acute myeloid leukaemia with myelodysplastic features in children: a report of Japanese Paediatric Leukaemia/Lymphoma Study Group
Kinoshita, Akitoshi
Miyachi, Hayato
Matsushita, Hiromichi
Yabe, Miharu
Taki, Tomohiko
Watanabe, Tomoyuki
Saito, Akiko M.
Tomizawa, Daisuke
Taga, Takashi
Takahashi, Hiroyuki
Matsuo, Hidemasa
Kodama, Kumi
Ohki, Kentaro
Hayashi, Yasuhide
Tawa, Akio
Horibe, Keizo
Adachi, Souichi
BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (01) : 80 - 86
[3] Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia
Zwaan, CM
Kaspers, GJL
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (03) : 264 - 279
[4] Treatment of relapsed/refractory acute myeloid leukaemia in adults
Rashidi, Armin
Weisdorf, Daniel J.
Bejanyan, Nelli
BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (01) : 27 - 37
[5] Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia
Karlsson, Lene
Cheuk, Daniel
De Moerloose, Barbara
Hasle, Henrik
Jahnukainen, Kirsi
Juul-Dam, Kristian Lovvik
Kaspers, Gertjan
Kovalova, Zanna
Lausen, Birgitte
Nystrom, Ulrika Noren
Palle, Josefine
Pronk, Cornelis Jan
Saks, Kadri
Tierens, Anne
Zeller, Bernward
Abrahamsson, Jonas
BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (04) : 757 - 765
[6] Cytogenetic Abnormalities and Their Impact on Treatment Outcome in Paediatric Acute Myeloid Leukaemia in Pakistan
Khalil, Sumaira
Ghafoor, Tariq
Farah, Tanzeela
Arshad, Awais
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2020, 30 (04): : 379 - 384
[7] Beginning treatment for paediatric acute myeloid leukaemia: diagnosis and the early hospital experience
McGrath, P
Paton, MA
Huff, N
SCANDINAVIAN JOURNAL OF CARING SCIENCES, 2004, 18 (04) : 358 - 367
[8] Clinical and biological features of paediatric acute myeloid leukaemia (AML) with primary induction failure in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study
Miyamura, Takako
Moritake, Hiroshi
Nakayama, Hideki
Tanaka, Shiro
Tomizawa, Daisuke
Shiba, Norio
Saito, Akiko M.
Tawa, Akio
Shimada, Akira
Iwamoto, Shotaro
Hayashi, Yasuhide
Koike, Takashi
Horibe, Keizo
Manabe, Atsushi
Mizutani, Shuki
Taga, Takashi
Adachi, Souichi
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (02) : 284 - 288
[9] Predisposition to prolonged neutropenia after chemotherapy for paediatric acute myeloid leukaemia is associated with better prognosis in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study
Aoki, Takahiro
Takahashi, Hiroyuki
Tanaka, Shiro
Shiba, Norio
Hasegawa, Daiichiro
Iwamoto, Shotaro
Terui, Kiminori
Moritake, Hiroshi
Nakayama, Hideki
Shimada, Akira
Koh, Katsuyoshi
Goto, Hiroaki
Kosaka, Yoshiyuki
Saito, Akiko M.
Horibe, Keizo
Kinoshita, Akitoshi
Tawa, Akio
Taga, Takashi
Adachi, Souichi
Tomizawa, Daisuke
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (01) : 176 - 180
[10] Treatment rates of paediatric acute myeloid leukaemia: a view from three tertiary centres in India
Gupta, Vineet G.
Arora, Brijesh
Radhakrishnan, Venkatraman
Banavali, Shripad
Bakhshi, Sameer
BRITISH JOURNAL OF HAEMATOLOGY, 2016, 175 (02) : 346 - 347

← 1 2 3 4 5 →